Nitrogen Fixation: Waltzing around cofactors
Nitrogen is an element that is found in nearly all important biological molecules, including amino acids and nucleic acids. Nitrogen is also abundant in our atmosphere in the form of N2 molecules, but this form of the element cannot be used biologically, so N2 must be transformed or “fixed” into biologically reactive compounds such as ammonia (NH3) and nitrate (NO3-).
Nature employs enzymes called nitrogenases to fix nitrogen. These enzymes rely on “cofactors” to perform their chemistry: the most widely studied of these cofactors contains iron and molybdenum, and hence is called the FeMo-cofactor (Figure 1). Despite the fact that nitrogenase activity was discovered in 1934, a comprehensive understanding of how it works has remained elusive due to the intrinsic complexity of both the FeMo-cofactor and the nitrogen fixation reaction (Hoffman et al., 2014). Now, in eLife, Thomas Spatzal, Kathryn Perez, James Howard and Douglas Rees report that some of the atoms that make up the FeMo-cofactor migrate in unexpected ways during catalysis (Spatzal et al., 2015).
Molybdenum nitrogenase is an enzyme that contains a molybdenum-iron protein (which is catalytic) and an iron protein (which is involved in electron transfer). The molybdenum-iron protein is home to the FeMo-cofactor and a cluster of iron and sulfur atoms that transfers electrons between the iron protein and the FeMo-cofactor. During the reaction cycle, the FeMo-cofactor orchestrates the reduction of two distinct substrates, N2 and H+, and allocates hydrogen atoms into products (NH3 or H2). Elucidating a detailed mechanism for this process is important for understanding how molybdenum nitrogenase is able to achieve this challenging chemical transformation.
To clarify how substrates bind to the FeMo-cofactor, Rees and co-workers previously solved a high-resolution X-ray crystal structure of the molybdenum-iron protein bound to carbon monoxide, a molecule that inhibits the cofactor (Spatzal et al., 2014). Unexpectedly, this structure revealed that carbon monoxide replaces the sulfur atom at the S2B position in the FeMo-cofactor; this atom is one of three "belt sulfurs" that form bridges between pairs of iron atoms in the cofactor (Figure 1). Significantly, this process is reversible; reactivated molybdenum-iron protein was shown to once again contain sulfur in the S2B position. These structures serve to shed light on substrate binding in molybdenum nitrogenase and suggest a previously unanticipated kinetic instability, or lability, of the FeMo-cofactor.
Inspired by this apparent lability of the FeMo-cofactor, Spatzal, Perez et al. – who are based at the California Institute of Technology and the University of Minnesota – have now developed a means of labeling the S2B site of the FeMo-cofactor with selenium, the element immediately below sulfur in the periodic table. Selenocyanate is a compound that contains selenium, and has recently been identified as a substrate and inhibitor of nitrogenase. Spatzal, Perez et al. therefore used X-ray crystallography to identify changes in the molybdenum-iron protein after nitrogenase had reacted with selenocyanate. In particular, they used the fact that selenium scatters X-rays differently from sulfur to confirm that selenium replaces sulfur at the S2B position, further strengthening the notion that S2B is a labile element in the FeMo-cofactor.
Spatzal, Perez et al. then showed that incorporating selenium into the FeMo-cofactor does not alter the catalytic activity of the enzyme. Taking a series of crystallographic snapshots of the selenium-containing cofactor at different stages of catalysis revealed that under turnover conditions, selenium migrates to the other two belt-sulfur positions. Selenium is then replaced by sulfur after reacting with multiple substrates. However, this migration of selenium is only observed when N2 or acetylene (C2H2) are used as substrates, and not when H+ is the exclusive substrate.
Before this work, the dogma in the field was that the atoms in the FeMo-cofactor and other metallocofactors provide a rigid scaffold on which chemistry can be performed, with movements restricted to protein sidechains, substrates and products. Now we must consider that in nitrogenase – and potentially other enzymes – the atoms of metallocofactors may actively change positions and that this dynamic nature may be substrate-specific.
The work of Spatzal, Perez et al. raises many additional questions. For example, how does belt-sulfur migration correlate with the reaction mechanism? And how are the structural dynamics of the FeMo-cofactor coupled to the reduction of different substrates? It also provides a powerful tool for interrogating the FeMo-cofactor through site-specific selenium incorporation. Already this method has allowed us to see selenium waltzing around the FeMo-cofactor center, and it is hard to imagine what surprises this enzyme has in store for us next.
References
-
Mechanism of molybdenum nitrogenaseChemical Reviews 96:2983–3012.https://doi.org/10.1021/cr950055x
-
Mechanism of nitrogen fixation by nitrogenase: the next stageChemical Reviews 114:4041–4062.https://doi.org/10.1021/cr400641x
-
How many metals does it take to fix N2? A mechanistic overview of biological nitrogen fixationProceedings of the National Academy of Sciences of the USA 103:17088–17093.https://doi.org/10.1073/pnas.0603978103
Article and author information
Author details
Publication history
Copyright
© 2016, Chen et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,091
- views
-
- 133
- downloads
-
- 2
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Biochemistry and Chemical Biology
- Genetics and Genomics
Yerba mate (YM, Ilex paraguariensis) is an economically important crop marketed for the elaboration of mate, the third-most widely consumed caffeine-containing infusion worldwide. Here, we report the first genome assembly of this species, which has a total length of 1.06 Gb and contains 53,390 protein-coding genes. Comparative analyses revealed that the large YM genome size is partly due to a whole-genome duplication (Ip-α) during the early evolutionary history of Ilex, in addition to the hexaploidization event (γ) shared by core eudicots. Characterization of the genome allowed us to clone the genes encoding methyltransferase enzymes that catalyse multiple reactions required for caffeine production. To our surprise, this species has converged upon a different biochemical pathway compared to that of coffee and tea. In order to gain insight into the structural basis for the convergent enzyme activities, we obtained a crystal structure for the terminal enzyme in the pathway that forms caffeine. The structure reveals that convergent solutions have evolved for substrate positioning because different amino acid residues facilitate a different substrate orientation such that efficient methylation occurs in the independently evolved enzymes in YM and coffee. While our results show phylogenomic constraint limits the genes coopted for convergence of caffeine biosynthesis, the X-ray diffraction data suggest structural constraints are minimal for the convergent evolution of individual reactions.
-
- Biochemistry and Chemical Biology
- Structural Biology and Molecular Biophysics
The SARS-CoV-2 main protease (Mpro or Nsp5) is critical for production of viral proteins during infection and, like many viral proteases, also targets host proteins to subvert their cellular functions. Here, we show that the human tRNA methyltransferase TRMT1 is recognized and cleaved by SARS-CoV-2 Mpro. TRMT1 installs the N2,N2-dimethylguanosine (m2,2G) modification on mammalian tRNAs, which promotes cellular protein synthesis and redox homeostasis. We find that Mpro can cleave endogenous TRMT1 in human cell lysate, resulting in removal of the TRMT1 zinc finger domain. Evolutionary analysis shows the TRMT1 cleavage site is highly conserved in mammals, except in Muroidea, where TRMT1 is likely resistant to cleavage. TRMT1 proteolysis results in reduced tRNA binding and elimination of tRNA methyltransferase activity. We also determined the structure of an Mpro-TRMT1 peptide complex that shows how TRMT1 engages the Mpro active site in an uncommon substrate binding conformation. Finally, enzymology and molecular dynamics simulations indicate that kinetic discrimination occurs during a later step of Mpro-mediated proteolysis following substrate binding. Together, these data provide new insights into substrate recognition by SARS-CoV-2 Mpro that could help guide future antiviral therapeutic development and show how proteolysis of TRMT1 during SARS-CoV-2 infection impairs both TRMT1 tRNA binding and tRNA modification activity to disrupt host translation and potentially impact COVID-19 pathogenesis or phenotypes.